EvidenceLib · Open textbook · CC BY 4.0
OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16–25 years: a RCT
Philip Asherson, Lena Johansson, Rachel Holland, Megan Bedding, Andrew Forrester, Laura Giannulli, Ylva Ginsberg, Sheila Howitt, Imogen Kretzschmar, Stephen Lawrie, Craig Marsh, Caroline Kelly, Megan Mansfield, Clare McCafferty, Khuram Khan, Ulrich Müller-Sedgwick, John Strang, Grace Williamson, Lauren Wilson, Susan Young, Sabine Landau, Lindsay Thomson · 8 sections in 8 chapters. Each section is its own page.
Introduction
Methods
Trial management, procedures and timelines
Results
Additional analyses
Discussion (including interpretation, generalisability, overall evidence)
References
Acknowledgements
Attribution. Philip Asherson; Lena Johansson; Rachel Holland; Megan Bedding; Andrew Forrester; Laura Giannulli et al. (2022). OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16–25 years: a RCT. National Institute for Health and Care Research. Copyright © 2022 Asherson et al. This work was produced by Asherson et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited. Licensed under CC BY 4.0. NCBI Bookshelf NBK581759. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.